Epigenetic therapy supplements docetaxel in the treatment of lung cancer: an in vitro evaluation

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: JAIN, Prateek (Decision Resources Group, Biopharma Insights, Gurgaon, India)
  • Co-author(s): Nayanabhirama Udupa Manipal University, India
    Prateek Jain
  • Abstract:


    The cells were cultured and maintained in DMEM, supplemented with 10% (v/v) FBS and 1% (v/v) penicillin/streptomycin (100,000 U/l penicillin, 100 mg/l streptomycin), at 37˚C in a humidified atmosphere containing 5% carbon dioxide. The cell viability was studied by MTT assay. DEC, DTX and DEC+DTX were dissolved in the culture medium and


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login